Liposomal amphotericin B treatment in a 9-month-old liver recipient.
A 9-month-old boy with a suggested candidemia was treated with liposomal amphotericin B (AmBisome, Vestar) after a liver transplant due to an inherited glycogenosis (Pompe's disease). This is believed to be the youngest patient in which this new therapeutic agent has been utilized.
Tollemar
J
J
Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Duraj
F
F
Ericzon
B G
BG
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D004337:Drug Carriers; D006009:Glycogen Storage Disease Type II / Q000601:surgery; D006801:Humans; D007223:Infant; D008081:Liposomes; D016031:Liver Transplantation; D008297:Male
D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B